Genetic testing for hereditary cancers: The impact of gender on interest, uptake and ethical considerations

Critical Reviews in Oncology/Hematology

Volumn 58, Issue 2, 2006, Pages 114-123

  d'Agincourt Canning, Lori ^a,b   Baird, Patricia ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ethics; Gender; Genetic testing; Hereditary cancer

Indexed keywords

BREAST CANCER; CANCER RISK; CLINICAL RESEARCH; COLORECTAL CANCER; FAMILIAL CANCER; GENETIC ANALYSIS; GENETIC PROCEDURES; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HEALTH STATUS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MEDICAL TECHNOLOGY; OUTCOMES RESEARCH; OVARY CANCER; PSYCHOLOGICAL ASPECT; REPRODUCTION; REVIEW; SEX DIFFERENCE; SEXUALITY; SOCIAL ASPECT; THEORETICAL STUDY; TREATMENT OUTCOME;

BIOETHICAL ISSUES; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC SCREENING; GENETIC TESTING; HEALTH SERVICES ACCESSIBILITY; HEREDITY; HUMANS; MALE; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; SEX FACTORS;

EID: 33646069662     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2006.03.001     Document Type: Review

References (108)

1. Sanderson S.C., Wardle J., Jarvis M.J., and Humphries S.E. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med 39 (2004) 458-464
2. Ross L., and Moon M. Ethical issues in pediatric genetics. In: Mahowald M., McKusick V., Scheuerle A., and Aspinwall T. (Eds). Genetics in the clinic: clinical, ethical, and social implications for primary care (2001), Mosby Inc., St. Louis 153-166
3. Anderson J. Toward a post-colonial feminist methodology in nursing research. Nurse Res 9 (2002) 7-27
4. Jonsen A. Genetic testing, individual rights and the common good. In: Campbell C.S., and Lustig B.A. (Eds). Duties to others (1994), Kluwer Academic Publishers, Dordrecht, The Netherlands 279-291
5. Knoppers B.M., and Godard B. Ethical and legal perspectives on inherited cancer susceptibility. In: Foulkes W., and Hodgson S. (Eds). Inherited susceptibility to cancer: clinical, predictive and ethical perspectives (1998), Cambridge University Press, Cambridge 30-45
6. Doyal L. Gender equity in health: debates and dilemmas. In: Bendelow G., Carpenter M., Vautier C., and Williams S. (Eds). Gender, health and healing: the public/private divide (2002), Routledge, London 183-197
7. Wizeman T., and Pardue M. Exploring the biological contributions to human health: does sex matter? (2001), National Academy Press, Washington, DC
8. Vlassoff C., and Moreno C.G. Placing gender at the centre of health programming: challenges and limitations. Social Sci Med 54 (2002) 1713-1723
9. Asch A., and Geller G. Feminism, bioethics and genetics. In: Wolf S. (Ed). Feminism and bioethics: beyond reproduction (1996), Oxford University Press, New York 318-350
10. Greaves L., Hankivsky O.C.A., et al. CIHR 2000: sex, gender and women's health (1999), British Columbia Centre of Excellence for Women's Health, Vancouver
11. Stacey M. The new genetics: a feminist view. In: Marteau T., and Richards M. (Eds). The troubled helix: social and psychological implications of the new human genetics (1996), Cambridge University Press, Cambridge 331-349
12. Pinn V.W. The view from the National Institutes of Health: a decade with the office of research on women's health. Gender Med 1 1 (2004) 5-7
13. Donner L., and Pederson A. Primary health care reform and women: a discussion paper. National workshop on women and primary health care (2004) 25
14. Philpott S., Boynton P.M., Feder G., and Hemingway H. Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Social Sci Med 52 (2001) 1565-1575
15. Vaccarino V., Krumholtz H.M., Yarzebski J., Gore M., and Goldberg R.G. Sex-based differences in early mortality after myocardial infarction. Ann Internal Med 134 (2001) 173-181
16. Wong Y., Rodwell S., Dawkins S., Livesay S.A., and Simpson I.A. Sex differences in investigations results and treatment: subjects referred for investigation of chest pain. Heart 85 (2001) 149-152
17. Grace S.L., Abbey S.E., Bisaillon S., Shneck Z., Irvine J., and Stewart O. Presentation, delay and contraindication to thrombolytic treatments in females and males with myocardial infarction. Women Health Issues 13 (2003) 214-221
18. Weisz D., Gusmano M., and Rodwin V. Gender and the treatment of heart disease in older persons in the U.S., France and England. Gender Med 1 1 (2004) 29-40
19. Vaccarino V., Parsons L., Every N.R., Barron H.V., and Krumholtz H.M. Sex-based differences in early mortality after myocardial infarction. New Engl J Med 341 (1999) 217-225
20. Armstrong P., Grant K., Boscoe M., et al. Primary health care reform and women (2005), Bureau of Women's Health and Gender Analysis, Health Canada, Ottawa
21. Grant K. Is there a method to this madness? Studying health care reform as if women mattered (2000), National Coordinating Group on Health Care Reform and Women Centres of Excellence for Women's Health Program,Women's Bureau, Health Canada, Ottawa
22. Dresser R. Wanted: single white males for medical research. The Hastings Center Report 1992;22(1):22-9.
23. United Nations. Convention on the elimination of all forms of discrimination against women (1996), United Nations Department of Public Information, New York
24. Annandale E. Gender and health status: does biology matter?. In: Williams S., Birke L., and Bendelow G. (Eds). Debating biology: sociological reflections in health (2003), Routledge, New York 85-95
25. Gonzalez J.M., Balsalobre M.D., Pomares F., et al. Prophylactic thyroidectomy in MEN2A syndrome: experience in a single center. J Am Coll Surg 195 (2002) 159-166
26. Clauss E., Risch N., et al. Genetic analysis of breast cancer in the cancer and steroid human study. Am J Med Genet 48 (1991) 232-242
27. Newman B., Mu H., Butler L.M., Milikan R.C., Moorman P.G., and King M.C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J Am Med Assoc 279 (1998) 915-921
28. Chung D.C. The genetic basis of colorectal cancer: insights into critical pathways of tumorgenesis. Gastroenterology 119 (2000) 854-865
29. Nystrom-Lahti M., Parsons R., Sistonen P., et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Human Genet 55 (1994) 659-665
30. Peltomaki P., Aaltonen L.A., Sistonen P., et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260 (1993) 810-812
31. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. J Am Med Assoc 277 (1997) 997-1003
32. Muto M. Genetic predisposition testing: taking the lead. Gynecol Oncol 67 (1997) 121-122
33. Olopade O. The human genome project and breast cancer. Women Health Issues 7 (1997) 209-213
34. Ponder B. Genetic testing for cancer risk. Science 278 (1997) 1050-1054
35. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutations carriers: the PROSE study group. J Clin Oncol 22 (2004) 981-983
36. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. J Am Med Assoc 292 (2004) 1317-1325
37. Sherwin S. No longer patient: feminist ethics and healthcare (1992), Temple University Press, Philadelphia
38. Chadwick R., and Levitt M. Euroscreen: ethical and philosophical issues of genetic screening in Europe. J R Coll Phys London 30 (1996) 67-69
39. Cox S.M. 'There's this thing in our family': predictive testing and the construction of risk for Huntington disease. Sociol Health Illness 21 5 (1999) 622-646
40. Burgess M. Beyond consent: ethical and social issues in genetic testing. Nat Rev Genet 2 (2001) 9-14
41. Henderson G. Research in medical ethics: genetic diagnosis. In: Sugarman H., and Sulmasy D. (Eds). Methods in medical ethics (2001), Georgetown University Press, Washington, DC 267-285
42. Sherwin S., and Simpson C. Ethical questions in the pursuit of genetic information: geneticization and BRCA1. In: Thompson A., and Chadwick R. (Eds). Genetic information: acquisition, access and control (1999), Kluwer Academic/Plenum Publishers, New York 121-128
43. Chaliki H., Loader S., Levenkron J.C., Logan-Young W., Hall W.J., and Rowley P.T. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85 (1995) 1133-1135
44. Julian-Reynier C., Eisinger F., Vennin P., et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 33 (1996) 731-736
45. Lerman C., Daly M., Masny M., and Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12 (1994) 843-850
46. Brain K., Gray J., Norman P., et al. Why do women attend familial breast cancer clinics?. J Med Genet 37 (2000) 197-202
47. Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., and Bonney G. BRCA1 testing in families with hereditary breast/ovarian cancer. A prospective study of patient decision-making and outcomes. J Am Med Assoc 275 (1996) 1885-1892
48. Andrykowski M., Lightner R., Studts J.L., and Munn R.K. Hereditary cancer risk notification and testing: how interested is the general population?. J Clin Oncol 15 (1997) 2139-2148
49. Donovan K., and Tucker D. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a socio-demographically diverse sample. J Behav Med 23 (2000) 15-36
50. Croyle R.T., and Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 22 (1993) 284-292
51. Tambor E., Rimer B., and Strigo T. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet 68 (1997) 43-49
52. Bottorff J., Ratner P.A., Balneaves L., et al. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. Cancer Epidemiol Biomar Prev 11 (2002) 89-95
53. Richards D., Ward P., Roa B., et al. Screening for 185delAG in the Ashkenazim. Am J Med Genet 60 (1997) 1085-1098
54. Phillips K.-A., Warner E., Meschino W., et al. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet 57 (2000) 376-383
55. Aro A.R., Hakonen A., Hietala M., et al. Acceptance of genetic testing in a general population: age, education and gender differences. Patient Educ Couns 32 (1997) 41-49
56. Glanz K., Grove J., Lerman C., Gotay C., and Le Marchand L. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomar Prev 8 (1999) 329-336
57. Lerman C., Marshall J., Audrain J., and Gomez-Caminero A. Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. Int J Cancer 69 (1996) 58-61
58. Petersen G.M., Larkin E.K., Codori A.M., et al. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomar Prev 8 (1999) 334-337
59. Wagner A., Tops C., Wijnen J., et al. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1 or MSH6 mutation. J Med Genet 39 (2002) 833-837
60. Hadley D.W., Jenkins J., Dimond E., et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Internal Med 163 (2003) 573-582
61. Doukas D.J., Localio R., and Li Y. Attitudes and beliefs concerning prostate cancer genetic screening. Clin Genet 66 (2004) 445-451
62. Myers R.E., Hyslop T., Jennings-Dozier K., et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomar Prev 9 (2000) 1323-1328
63. Bratt O., Damber J.E., Emanuelsson M., et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36 (2000) 235-241
64. Bratt O., Kristoffersson U., Lundgren R., and Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 50 (1997) 360-365
65. Diefenbach M.A., Schnoll R.A., Miller S.M., and Bower L. Genetic testing for prostate cancer: willingness and predictors of interest. Cancer Pract 1 (2000) 1-6
66. Kinney A.Y., Choi Y.A., DeVellis B., Kobertz E., Millikan R.C., and Sanders R.S. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med 18 (2000) 249-252
67. Craufurd D., Dodge A., Kerzin-Storrar L., and Harris R. Uptake of presymptomatic testing for Huntington's disease. Lancet ii (1989) 603-605
68. Tambor E., Bernhardt B., Chase G.A., et al. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Human Genet 55 (1994) 626-637
69. Creighton S., Almqvist E.W., MacGregor D., et al. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 63 (2003) 462-475
70. Harper P.S., Lim C., and Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's disease prediction consortium. J Med Genet 37 (2000) 567-571
71. Maat-Kievit A., Vegter-van der Vlis M., Zoeteweij M., Losekoot M., van Haeringen A., and Roos R. Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiat 69 (2000) 579-583
72. Hartenbach E., Becker J., et al. Progress of a comprehensive familial cancer genetic counseling program in the era of BRCA1 and BRCA2. Genet Test 6 (2002) 75-78
73. Lerman C., Hughes C., Trock B.J., et al. Genetic testing in families with hereditary nonpolyposis colon cancer. J Am Med Assoc 281 (1999) 1618-1622
74. Evans D.G., Maher E.R., Macleod R., Davies D.R., and Draufurd D. Uptake of genetic testing for cancer predisposition. J Med Genet 34 (1997) 746-748
75. Balmana J., Stoffel E.M., Emmons K.M., Garber J.E., and Syngal S. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet Online 41 (2004) e44
76. Meiser B., Collins V., Warren R., et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 66 (2004) 502-511
77. Meijers-Heijboer E.J., Verhoog L.C., Brekelmans C.T., et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355 (2000) 2015-2020
78. Codori A.M., Zawacki K., Petersen G.M., et al. Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A 116 (2003) 117-128
79. Codori A.M., Petersen G.M., Boyd P.A., Brandt J., and Giardello F.M. Genetic testing for cancer in children: short-term psychological effects. Arch Pediat Adol Med 150 (1996) 1131-1138
80. Michie S., Bobrow M., and Marteau T. Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet 38 (2001) 519-526
81. Croyle R.T., Smith K.R., Botkin J., Baty B., and Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 16 1 (1997) 63-72
82. Meiser B., Butow P., Friedlander M., et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 38 (2002) 2025-2031
83. d'Agincourt-Canning L. Genetic testing for hereditary cancer: challenges to ethical care in rural and remote communities. HEC Forum 16 (2004) 222-233
84. Surbone A. Ethical implications of genetic testing for breast cancer susceptibility. Crit Rev Oncol/Hematol 40 (2001) 149-157
85. Burgess M. Beyond consent: ethical and social issues in genetic testing. Nat Rev: Genet 2 (2001) 9-14
86. Henderson G.E. Research in medical ethics: genetic diagnosis. In: Sugarman H., and Sulmasy D. (Eds). Methods in medical ethics (2001), Georgetown University Press, Washington, DC 267-285
87. Knoppers B., and Godard B. Ethical and legal perspectives on inherited cancer susceptibility. In: Foulkes W., and Hodgson S. (Eds). Inherited susceptibility to cancer: clinical, predictive and ethical perspectives (1998), Cambridge University Press, Cambridge 30-45
88. Lemmens T., and Bahamin P. Genetics in life, disability and additional health insurance in Canada: a comparative legal and ethical analysis. In: Knoppers B. (Ed). Socio-ethical issues in human genetics (1998), Les Editions, Yvon Blais Inc., Quebec 107-275
89. Sommerville A., and English V. Genetic privacy: orthodoxy or oxymoron. J Med Ethics 25 (1999) 144-150
90. Weijer C. Family duty is more important than rights. Br Med J 321 (2000) 1466
91. Lippman A. The politics of health: geneticization versus health. In: Sherwin S. (Ed). The politics of women's health: exploring agency and autonomy (1998), Temple University Press, Philadelphia 64-82
92. Dodds S. Choice and control in feminist bioethics. In: Mackenzie C., and Stoljar N. (Eds). Relational autonomy: feminist perspectives on autonomy, agency and the social self (2000), Oxford University Press, New York 213-235
93. Sherwin S. A relational approach to autonomy in health care. In: Sherwin S. (Ed). The politics of women's health: exploring agency and autonomy (1998), Temple University Press, Philadelphia 19-47
94. Hallowell N. Doing the right thing: genetic risk and responsibility. Sociol Health Illness 21 5 (1999) 597-621
95. Foster C., Watson M., Moynihan C., et al. Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility. J Health Psychol 7 (2002) 469-484
96. Hallowell N., Foster C., Eeles R., Ardern-Jones A., Murday V., and Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 29 (2003) 74-83
97. d'Agincourt-Canning L. Experiential knowledge, moral agency and genetic testing for hereditary breast/ovarian cancer. Unpublished PhD dissertation. University of British Columbia; 2003.
98. Burgess M.M., and d'Agincourt-Canning L. Genetic testing for hereditary disease: attending to relational responsibility. J Clin Ethics 12 (2001) 361-372
99. d'Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 15 (2001) 231-247
100. Walker M.U. Moral understandings: a feminist study in ethics (1998), Routledge, New York
101. Sommerville A., and English V. Genetic privacy: orthodoxy or oxymoron. J Med Ethics 25 (1999) 144-150
102. Weijer C. Family duty is more important than individual rights. Br Med J 321 (2000) 1466
103. Graham H. Providers, negotiators and mediators: women as the hidden carers. In: Lewin E., and Olsen V. (Eds). Women, health and healing: toward a new perspective (1985), Tavistock Publications, New York 25-52
104. Richards M. Families, kinship and genetics. In: Marteau T., and Richards M. (Eds). The troubled helix: social and psychological implications of the new human genetics (1996), Cambridge University Press, Cambridge 249-273
105. Taylor S.D. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives. Social Sci Med 58 (2004) 137-149
106. Hartmann L.C., Sellers T.A., Schaid D.J., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J National Cancer Instit 93 (2001) 1633-1637
107. Shrag D., Kuntz K.M., Garber J., and Weeks J.C. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. J Am Med Assoc 283 (2000) 617-624
108. Chambliss D.F. Beyond caring: hospitals, nurses and the social organization of ethics (1996), University of Chicago Press, Chicago